Iron Chelation Therapy
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | eBook |
| Language: | English |
| Published: |
New York, NY :
Springer US : Imprint: Springer,
2002.
|
| Edition: | 1st ed. 2002. |
| Series: | Advances in Experimental Medicine and Biology,
509 |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-1-4615-0593-8 |
Table of Contents:
- Pathopysiology of Iron Overload
- 1.Animal Models of Hereditary Iron Transport Disorders
- 2.Mechanism of Iron Toxicity
- 3.Role of Non-Transferrin-Bound Iron in the Pathogenesis of Iron Overload and Toxicity
- 4.Intacellular and Extracellular Labile Iron Pools
- 5.Cardioprotective Effect of Iron Chelators
- Chelation Therapy in Transfulional Siderosis
- 6.Results of Long Term Iron Chelation Treatment with Deferoxamine
- 7.Long Term Deferiprone Chelation Therapy
- Development of New Iron Chelators
- 8.Iron Chelator Chemistry
- 9.Structure-Activity Relationships Among Desazadesferrithiocin Analogues
- 10.ICL670A: Preclinical Profile
- 11.Pyridoxal Isonicotinoyl Hydrazone and Its Analogues
- Novel Strategies in Iron Chelation Treatment
- 12.Therapeutic Potential of Iron Chelators in Cancer Therapy
- 13.Antimalarial Effect of Iron Chelators.